SMTL ID : 5exn.1

FACTOR XIA (C500S [C122S]) IN COMPLEX WITH THE INHIBITOR methyl ~{N}-[4-[2-[(1~{S})-1-[[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 1.49 Å
Oligo State
monomer
Ligands
1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
1 x 5SU: methyl ~{N}-[4-[2-[(1~{S})-1-[[(~{E})-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-2-phenyl-ethyl]pyridin-4-yl]phenyl]carbamate(Non-covalent)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Corte, J.R. et al., Orally bioavailable pyridine and pyrimidine-based Factor XIa inhibitors: Discovery of the methyl N-phenyl carbamate P2 prime group. Bioorg.Med.Chem. (2016)
Release Date
2016-04-13
Peptides
Coagulation factor XIa light chain: A
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A

Coagulation factor XIa light chain

Related Entries With Identical Sequence

3sor.1 | 3sos.1 | 4x6p.1 | 4x6p.2 | 6hhc.1 | 6r8x.1 | 6ts5.1 | 6ts6.1 | 6ts7.1 | 6usy.1 | 6vlu.1 | 6vlv.1 | 7mbo.1 | 7v0z.1 | 7v10.1 | 7v11.1 | 7v12.1 | 7v13.1 | 7v14.1 | 7v15.1 | 7v16.1 | 7v17.1 | 7v18.1 | 8bo3.1 | 8bo4.1 | 8bo5.1 | 8bo6.1 | 8bo7.1